Brief: Inhibitor Therapeutics Receives Prostate Cancer IND Clearance From FDA
22/01/2020 13:11
Jan 22 (Reuters) - Inhibitor Therapeutics Inc INTI.PK :
* INHIBITOR THERAPEUTICS RECEIVES PROSTATE CANCER IND
CLEARANCE
FROM FDA
Source text for Eikon: ID:nPn5LGKnma
Further company coverage: INTI.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Inhibitor Therapeutics
See all newsBrief: Inhibitor Therapeutics Receives Prostate Cancer IND Clearance From FDA
Brief: Hedgepath Pharmaceuticals Provides Corporate Update For The Fourth Quarter And Year End 2018
Brief: Hedgepath Pharmaceuticals, Mayne Pharma Enter Updated Collaboration & Funding Agreements
Brief: HedgePath says FDA grants orphan drug designation to its pill